Planning notice observed
Latest variant observed by Bidwake on .
Open this official Find a Tender notice
Record references
- Release reference
035418-2026- Published tags
- planning
Loading records…
Public procurement
See the published facts, notice history, awards and supplier links in one place. Open the original Find a Tender notice for the full record.
ocds-h6vhtk-0685cfPublished facts
072622-2026The Future Medicines Institute (FMI) requires a high throughput live-cell imaging system to enable FMI scientists and collaborators to monitor live cell imaging in real time under optimal conditions of cell growth in a properly maintained carbon dioxide and humidity environment to enable the efficient capture of cellular changes as they happen in the incubator. The objective of procuring a live cell imaging system is to enhance FMI’s capacity to monitor cells in real time, in an optimally controlled environment, to support and strengthen its drug discovery capabilities. The proposed system must: • Be capable of multiplate/vessel imaging, up to a capacity of 6 plates/vessels and including capacity to image 6 384 well plates, to meet the volume of analysis that the centre is undertaking and support high throughput drug screening projects. • Enable high resolution fluorescence and bright field images to be captured and recorded in real time over hours, days, or weeks. • Offer flexibility to enable users to observe and quantify complex biological changes over time in cells and 3d structures such as spheroids and organoid models. • Include a fully integrated image acquisition system to capture real-time insight into morphological and phenotypic changes and allow multiple users the opportunity to perform complex cellular assays. • Offer versatile assay configurations, supporting various experimental formats such as 2d cell systems and 3d spheroid, and organoid models. The procurement of this live cell imaging system directly supports FMI’s broader goals of: • Accelerating drug discovery through rapid identification and characterisation of therapeutic candidates • Providing screening capabilities in high-throughput format • Facilitating translational research by bridging fundamental cellular studies with therapeutic applications. The procurement of a live cell imaging system will provide direct benefit to research scientists within FMI, and wider stakeholders such as partner organisations and the wider academic community in Queens University Belfast (QUB) by: • Significantly enhance its cellular screening capabilities. • Enhancing live cell imaging capabilities and data acquisition throughput in optimised cellular conditions. • Reducing time in setting up multiple vessels for multiple time point experiments. • Reducing plasticware consumables and expensive reagents currently used in setting up multiple time point experiments. If funding becomes available to address future expansion needs the University reserves the right to purchase additional Live-Cell Imaging Systems during the life of the contract. Subject to the availability of funding, the University may optionally purchase additional Live Cell Imaging Systems during the term of the contract. Any such additional purchases shall be non guaranteed, limited to the optional items and maximum quantities and/or values set out in the Pricing Schedule, and shall have been included in the estimated contract value for the purposes of this procurement.
Observed notice trail
Events follow the publisher date where one is available. “Seen by Bidwake” is the date this service first found the record.
Planning notice observed
Latest variant observed by Bidwake on .
Open this official Find a Tender notice
035418-2026Tender notice observed
Latest variant observed by Bidwake on .
Open this official Find a Tender notice
035421-2026Award notice observed
Latest variant observed by Bidwake on .
Open this official Find a Tender notice
058539-2026Award notice observed
Latest variant observed by Bidwake on .
Open this official Find a Tender notice
Awards and suppliers
Buyer: Queen's University BelfastSupplier: SARTORIUS UK LIMITED
1End dates, recurrence wording and links are shown as they appear in public notices. They do not create a new opportunity. If no later linked record appears here, that means Bidwake did not find one in the records it has loaded; it does not prove that none exists.
072622-2026